Ability to Regulate Emotion Is Predicted by Depressive Symptoms and Cognitive Function in a Cardiac Sample.
Mary Beth Spitznagel, PhD Assistant Professor, Department of Psychology, Kent State University, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Vanessa Potter, BA Research Coordinator, Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Lindsay A. Miller, BS Research Assistant, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Angela N. Roberts Miller, MS, MPH Research Assistant, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Joel Hughes, PhD Associate Professor, Department of Psychology, Kent State University, Ohio, and Summa Health System, Center for Cardiopulmonary Research, Akron, Ohio. Jim Rosneck, RN Director, Center for Cardiovascular Research, Summa Health System, Akron, Ohio. John Gunstad, PhD Associate Professor, Department of Psychology, Kent State University, Ohio, and Center for Cardiopulmonary Research, Summa Health System, Akron, Ohio.The Journal of cardiovascular nursing (Impact Factor: 2.05). 06/2012; 28(5). DOI: 10.1097/JCN.0b013e318256be99
BACKGROUND:: Reduced ability to regulate emotion is exhibited in depressed individuals as well as patients with neurocognitive change. Given that patients with cardiovascular disease (CVD) often exhibit both cognitive and mood changes, these could, in combination, lead to increased volatility of emotion. OBJECTIVE:: The current study examined the association between ability to regulate emotion, depressive symptoms, and cognitive function in a sample of patients with CVD. METHODS:: Ninety-one CVD patients referred for outpatient stress testing completed brief cognitive testing and self-report measures of emotion regulation and depressive symptoms. RESULTS:: Hierarchical multiple regression analyses revealed that depressive symptoms (P < .001) and executive function (P < .05) independently contribute to emotion regulation. The interaction between these variables demonstrates that elevated depressive symptoms and decreased executive function predict increased emotion dysregulation. CONCLUSION:: Findings suggest that in combination, elevated depressive symptoms and executive dysfunction contribute to poorer ability to regulate emotion in patients with CVD. Given the prevalence of depression and cognitive change in this population, these findings underscore the importance of clinician awareness of these issues in this population and suggest clinical implications for treatment of mental health issues, especially emotion regulation, in this population.
- [Show abstract] [Hide abstract]
ABSTRACT: The Mini-Mental State (MMS) examination is a widely used screening test for dementia. The Modified Mini-Mental State (3MS) incorporates four added test items, more graded scoring, and some other minor changes. These modifications are designed to sample a broader variety of cognitive functions, cover a wider range of difficulty levels, and enhance the reliability and the validity of the scores. The 3MS retains the brevity, ease of administration, and objective scoring of the MMS but broadens the range of scores from 0-30 to 0-100. Greater sensitivities of the 3MS over the MMS are demonstrated with the pentagon item drawn by 249 patients. A summary form for administration and scoring that can generate both the MMS and the 3MS scores is provided so that the examiner can maintain continuity with existing data and can obtain a more informative assessment.The Journal of Clinical Psychiatry 09/1987; 48(8):314-8. · 5.50 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Smoking is a well-established risk factor for cardiovascular disease (CVD). This chapter provides an overview of a program of nursing research relevant to tobacco use in patients with CVD. The Women's Initiative for Nonsmoking (WINS) provides a rich demonstration of a key randomized clinical trial (RCT) on the efficacy of smoking cessation in women. The National Institutes of Health priority for data mining of existing RCTs is demonstrated in the numerous presentations of findings from secondary papers from WINS that answer additional research questions relevant to smoking cessation, including the influence of depression on smoking, myths about and underuse of nicotine replacement therapy. The methodological and logistical challenges inherent in tobacco intervention studies are presented, including a discussion of research needed in the measurement of withdrawal symptoms. Additionally, the role and contributions of nurses serving on the federal guideline development process are highlighted. International research activities of the coauthors from Jordan and Korea are also presented, including a discussion of the need for research in waterpipe use.Annual review of nursing research 12/2009; 27(1):221-42. DOI:10.1891/0739-6686.27.221
- [Show abstract] [Hide abstract]
ABSTRACT: : To conduct a meta-analysis evaluating the effectiveness of depression treatment on mental and physical health-related quality of life (HRQOL) of cardiac patients. : Studies were identified using medical, health, psychiatry, psychology, and social sciences databases. Inclusion criteria were (1) 1 or more control conditions, (2) random assignment to condition after admission for myocardial infarction (MI)/acute coronary syndrome, after recording positive results on a depression screener, (3) documentation of depression symptoms at baseline, (4) depression management as a component of the rehabilitation/intervention, (5) validated measure of HRQOL as an outcome, at minimum 6-month followup. For meta-analysis, mental and physical HRQOL were the end points studied, using standardized mean differences for continuous outcome measures, with 95% confidence intervals. Heterogeneity was explored by calculating I statistic. : Five randomized controlled trials included in the analysis represented 2105 participants (1058 intervention vs 1047 comparator). Compared with a comparator group at 6 months, a test for overall effect demonstrated statistically significant improvements in mental HRQOL in favor of the intervention (standardized mean differences = -0.29 [-0.38 to -0.20], [P < .00001]; I = 0%). Depression treatment had a modest yet significant impact on physical HRQOL (standardized mean differences = -0.14 [-0.24 to -0.04] [P = .009]; I = 15%). : While the impact of post-MI depression interventions on physical HRQOL is modest, treatment can improve mental HRQOL in a significant way. Future research is required to develop and evaluate a program that can achieve vital improvements in overall HRQOL, and potentially cardiovascular outcomes, of cardiac patients.Journal of cardiopulmonary rehabilitation and prevention 12/2010; 31(3):146-56. DOI:10.1097/HCR.0b013e3181fc0985 · 1.58 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.